CHR-2797 (tosedostat)
CHR-2797-001
Phase 1 small_molecule completed
Quick answer
CHR-2797 (tosedostat) for Advanced Solid Tumors is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed